The inhibition of apoptosis by glycyrrhizin in hepatic injury induced by injection of lipopolysaccharide / D-galactosamine in mice

Archives of Histology and Cytology

Volumn 71, Issue 3, 2008, Pages 163-178

  Ikeda, Tadayuki ^a   Abe, Kazuki ^b   Kuroda, Noriyuki ^a   Kida, Yujiro ^a   Inoue, Hideo ^b   Wake, Kenjiro ^a   Morito, Mitsuhiko ^a   Sato, Tetsuji ^a  

^a TSURUMI UNIVERSITY   (Japan)

^b Minophagen Pharmaceutical Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CASPASE 3; CASPASE 8; GALACTOSAMINE; GLYCYRRHIZIC ACID; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE;

ACUTE HEPATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA FRAGMENTATION; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER INJURY; MALE; MICRODISSECTION; MOUSE; NICK END LABELING; NONHUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CASPASES; GALACTOSAMINE; GLYCYRRHIZIC ACID; HEPATITIS, TOXIC; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; INJECTIONS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; TIME FACTORS;

EID: 59949085550     PISSN: 09149465     EISSN: 13491717     Source Type: Journal    
DOI: 10.1679/aohc.71.163     Document Type: Article

References (42)

1. Ansari B, Coates PJ, Greenstein BD, Hall PA: In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170: 1-8 (1993).
2. Austyn JM, Gordon S: F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11: 805-815 (1981).
3. Danial NN, Korsmeyer SJ: Cell death: critical control points. Cell 116: 205-219 (2004).
4. Decker K, Keppler D: Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 71: 77-106 (1974).
5. Dinarello CA: Interleukin-18. Methods 19: 121-132 (1999).
6. Dinarello CA, Fantuzzi G: Interleukin-18 and host defense against infection. J Infect Dis 187 Suppl 2: S370-384 (2003).
7. Fukuda T, Mogami A, Tanaka H, Yoshikawa T, Hisadome M, Komatsu H: Y-40138, a multiple cytokine production modulator, protects against D-galactosamine and lipopolysaccharide-induced hepatitis. Life Sci 79: 822-827 (2006).
8. Galanos C, Freudenberg MA, Reutter W: Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A 76: 5939-5943 (1979).
9. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501 (1992).
10. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal J, Sekut L, Talanian R, Paskind M, Wong M, Kamen R, Tracey D, Allen H: Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386: 619-623 (1997).
11. Gracie JA, Robertson SE, Mcinnes IB: Interleukin-18. J Leukoc Biol 73: 213-224 (2003).
12. Hase K, Xiong Q, Basnet P, Namba T, Kadota S: Inhibitory effect of tetrahydroswertianolin on tumor necrosis factor-alpha-dependent hepatic apoptosis in mice. Biochem Pharmacol 57: 1431-1437 (1999).
13. Ito A, Hayashi N, Katayama K, Hagiwara H, Kasahara A, Kashiwagi T, Yoshihara H, Fusamoto H, Kamada T: Effect of glycyrrhizin on viral replication and quasispecies in patients with type C chronic hepatitis. Int Hepatol Commu 6: 233-238 (1997).
14. Jia HY, Du J, Zhu SH, Ma YJ, Chen HY, Yang BS, Cai HF: The roles of serum IL-18, IL-10, TNF- alpha and sIL-2R in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int 1: 378-382 (2002).
15. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, Ferri KF, Zamzami N, Wakeham A, Hakem R, Yoshida H, Kong YY, Mak TW, Zúñiga-Pflücker JC, Kroemer G, Penninger JM: Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410: 549-554 (2001).
16. Kanakaraj P, Ngo K, Wu Y, Angulo A, Ghazal P, Harris C A, Siekierka JJ, Peterson PA, Fung-Leung WP: Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J Exp Med 189: 1129-1138 (1999).
17. Klener P, JR., Andera L, Klener P, Necas E, Zivny J: Cell death signalling pathways in the pathogenesis and therapy of haematologic malignancies: overview of apoptotic pathways. Folia Biol (Praha) 52: 34-44 (2006).
18. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146: 1220-1234 (1995).
19. Li L Y, Luo X, Wang X: Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412: 95-99 (2001).
20. Ludwiczek O, Kaser A, Novick D, Dinarello CA, Rubinstein M, Vogel W, Tilg H: Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. J Clin Immunol 22: 331-337 (2002).
21. Marin-Serrano E, Rodriguez-Ramos C, Diaz F, Martin-Herrera L, Giron-Gonzalez JA: Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin. J Viral Hepat 13: 230-234 (2006).
22. Nagata S: Apoptosis by death factor. Cell 88: 355-365 (1997).
23. Naito M, Takahashi K: The role of Kupffer cells in glucan-induced granuloma formation in the liver of mice depleted of blood monocytes by administration of strontium-89. Lab Invest 64: 664-674 (1991).
24. Nakahira M, Ahn HJ, Park WR, Gao P, Tomura M, Park CS, Gao P, Tomura M, Park CS, Hamaoka T, Ohta T, Kurimoto M, Fujiwara H: Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol 168: 1146-1153 (2002).
25. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19: 423-474 (2001).
26. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43 (1995).
27. Okamoto T: The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice. Eur J Pharmacol 387: 229-232 (2000).
28. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita H, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88-91 (1995).
29. Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P: Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 184: 2067-2072 (1996).
30. Sakao Y, Takeda K, Tsutsui H, Kaisho T, Nomura F, Okamura H, Nakanishi K, Akira S: IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int Immunol 11: 471-480 (1999).
31. Sasaki C, Sato T, Kozawa Y: Apoptosis in regressive deciduous tooth germs of Suncus murinus evaluated by the the TUNEL method and electron microscopy. Arch Oral Biol 46: 649-660 (2001).
32. Sass G, Heinlein S, Agli A, Bang R, Schumann J, Tiegs G: Cytokine expression in three mouse models of experimental hepatitis. Cytokine 19: 115-120 (2002).
33. Sato T, Yamamoto H, Sasaki C, Wake K: Maturation of rat dendritic cells during intrahepatic translocation evaluated using monoclonal antibodies and electron microscopy. Cell Tissue Res 294: 503-514 (1998).
34. Shapiro L, Puren AJ, Barton HA, Novick D, Peskind RL, Shenkar R, Gu Y, Su MS, Dinarello CA: Interleukin 18 stimulates HIV type 1 in monocytic cells. Proc Natl Acad Sci U S A 95: 12550-12555 (1998).
35. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446 (1999).
36. Takahara T, Watanabe A, Shiraki K: Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study. J Hepatol 21: 601-609 (1994).
37. Tiegs G, Wolter M, Wendel A: Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 38: 627-631 (1989).
38. Wang H, Li Y: Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. Eur J Pharmacol 534: 194-201 (2006).
39. Yamamura Y, Santa T, Kotaki H, Uchino K, Sawada Y, Iga T: Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability. Biol Pharm Bull 18: 337-341 (1995).
40. Yoshida T, Abe K, Ikeda T, Matsushita T, Wake K, Sato T, Sato T, Inoue H: Inhibitory effect of glycyrrhizin on lipopolysaccharide and D-galactosamine-induced mouse liver injury. Eur J Pharmacol 576: 136-142 (2007).
41. Yoshikawa M, Matsui Y, Kawamoto H, Umemoto N, Oku K, Koizumi M, Yamao J, Kuriyama S, Nakano H, Hozumi N, Ishizaka S, Fukui H: Effects of glycyrrhizin on immune-mediated cytotoxicity. J Gastroenterol Hepatol 12: 243-248 (1997).
42. Yumoto E, Higashi T, Nouso K, Nakatsukasa H, Fujiwara K, Hanafusa T, Yumoto Y, Tanimoto T, Kurimoto M, Tanaka N, Tsuji T: Serum gamma-interferon- inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol 17: 285-294 (2002).